Javier Zarranz-Ventura1, Pearse A Keane2, Dawn A Sim2, Victor Llorens3, Adnan Tufail2, Srinivas R Sadda4, Andrew D Dick5, Richard W Lee5, Carlos Pavesio2, Alastair K Denniston6, Alfredo Adan3. 1. Institut Clínic d'Oftalmologia, Hospital Clinic, Barcelona, Spain; National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology, London, United Kingdom; School of Clinical Sciences, Bristol Eye Hospital, University of Bristol, Bristol, United Kingdom. Electronic address: jzarranz@hotmail.com. 2. National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology, London, United Kingdom. 3. Institut Clínic d'Oftalmologia, Hospital Clinic, Barcelona, Spain. 4. Doheny Eye Institute, University of California Los Angeles, Los Angeles, California. 5. National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology, London, United Kingdom; School of Clinical Sciences, Bristol Eye Hospital, University of Bristol, Bristol, United Kingdom. 6. Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham National Health Service Foundation Trust, Birmingham, United Kingdom; Academic Unit of Ophthalmology, University of Birmingham, Birmingham, United Kingdom; Birmingham & Midland Eye Centre, Sandwell and West Birmingham National Health Service Trust, Birmingham, United Kingdom.
Abstract
PURPOSE: To evaluate a proposed method for objective measurement of vitreous inflammation using a spectral-domain optical coherence tomography (SD OCT) device in a large cohort of uveitis eyes, including pseudophakic eyes and vitrectomized eyes. DESIGN: Retrospective, observational cohort study. METHODS: One hundred five uveitis eyes (105 patients) with different vitreous haze score grades according to standardized protocols and corresponding SD OCT images (Cirrus HD-OCT; Carl Zeiss Meditec, Dublin, California, USA) were included. Clinical data recorded included phakic status, previous vitreoretinal surgery, and anterior chamber (AC) cells and flare. SD OCT images were analyzed using custom software that provided absolute measurements of vitreous (VIT) and retinal pigment epithelium (RPE) signal intensities, which were compared to generate a relative optical density ratio with arbitrary units (VIT/RPE-relative intensity) and compared to VHS. RESULTS: VIT/RPE-relative intensity showed a significant positive correlation with vitreous haze score (r = 0.535, P < .001) that remained significant after adjusting for factors governing media clarity, such as AC cells, AC flare, and phakic status (R(2)-adjusted = 0.424, P < .001). Significant differences were also observed between the different vitreous haze score groups (P < .001). Preliminary observation did not observe differences in VIT/RPE-relative intensity values between phakic and pseudophakic eyes (0.3522 vs 0.3577, P = .48) and between nonvitrectomized and vitrectomized eyes (0.3540 vs 0.3580, P = .52), overall and respectively for each vitreous haze score subgroup. CONCLUSIONS: VIT/RPE-relative intensity values provide objective measurements of vitreous inflammation employing an SD OCT device. Phakic status and previous vitrectomy surgery do not appear to influence these values, although these preliminary findings need validation in future studies.
PURPOSE: To evaluate a proposed method for objective measurement of vitreous inflammation using a spectral-domain optical coherence tomography (SD OCT) device in a large cohort of uveitis eyes, including pseudophakic eyes and vitrectomized eyes. DESIGN: Retrospective, observational cohort study. METHODS: One hundred five uveitis eyes (105 patients) with different vitreous haze score grades according to standardized protocols and corresponding SD OCT images (Cirrus HD-OCT; Carl Zeiss Meditec, Dublin, California, USA) were included. Clinical data recorded included phakic status, previous vitreoretinal surgery, and anterior chamber (AC) cells and flare. SD OCT images were analyzed using custom software that provided absolute measurements of vitreous (VIT) and retinal pigment epithelium (RPE) signal intensities, which were compared to generate a relative optical density ratio with arbitrary units (VIT/RPE-relative intensity) and compared to VHS. RESULTS: VIT/RPE-relative intensity showed a significant positive correlation with vitreous haze score (r = 0.535, P < .001) that remained significant after adjusting for factors governing media clarity, such as AC cells, AC flare, and phakic status (R(2)-adjusted = 0.424, P < .001). Significant differences were also observed between the different vitreous haze score groups (P < .001). Preliminary observation did not observe differences in VIT/RPE-relative intensity values between phakic and pseudophakic eyes (0.3522 vs 0.3577, P = .48) and between nonvitrectomized and vitrectomized eyes (0.3540 vs 0.3580, P = .52), overall and respectively for each vitreous haze score subgroup. CONCLUSIONS: VIT/RPE-relative intensity values provide objective measurements of vitreous inflammation employing an SD OCT device. Phakic status and previous vitrectomy surgery do not appear to influence these values, although these preliminary findings need validation in future studies.
Authors: Christopher L Passaglia; Tia Arvaneh; Erin Greenberg; David Richards; Brian Madow Journal: Transl Vis Sci Technol Date: 2018-03-23 Impact factor: 3.283
Authors: Lydia J Bradley; Amy Ward; Madeleine C Y Hsue; Jian Liu; David A Copland; Andrew D Dick; Lindsay B Nicholson Journal: Front Immunol Date: 2021-06-18 Impact factor: 7.561
Authors: G Montesano; C M Way; G Ometto; H Ibrahim; P R Jones; R Carmichael; X Liu; T Aslam; P A Keane; D P Crabb; A K Denniston Journal: Sci Rep Date: 2018-01-26 Impact factor: 4.379
Authors: Scott H Greenwald; Emily E Brown; Michael J Scandura; Erin Hennessey; Raymond Farmer; Basil S Pawlyk; Ru Xiao; Luk H Vandenberghe; Eric A Pierce Journal: Mol Ther Methods Clin Dev Date: 2020-07-09 Impact factor: 6.698
Authors: María Jesús Rodrigo; Manuel Subías; Alberto Montolío; Silvia Méndez-Martínez; Teresa Martínez-Rincón; Lorena Arias; David García-Herranz; Irene Bravo-Osuna; Julian Garcia-Feijoo; Luis Pablo; José Cegoñino; Rocio Herrero-Vanrell; Ana Carretero; Jesus Ruberte; Elena Garcia-Martin; Amaya Pérez Del Palomar Journal: Biomedicines Date: 2021-11-29
Authors: Xiaoxuan Liu; Benjamin Tk Hui; Christopher Way; Sophie Beese; Ada Adriano; Pearse A Keane; David J Moore; Alastair K Denniston Journal: Ocul Immunol Inflamm Date: 2020-10-06 Impact factor: 3.070